The article discusses the potential of biotech stocks under $20, focusing on Nuvation Bio Inc. and its promising pipeline in oncology. Despite risks, the biotech industry shows rapid growth driven by innovation and government support, offering high rewards for investors.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing